Skip to main content
Glama

Acled

by io.github.pipeworx-io

Compare Entities

compare_entities
Read-onlyIdempotent

"Compare X and Y" / "X vs Y" / "X versus Y" / "which is bigger / better / larger / more profitable" / "rank these companies" / "head to head" — side-by-side comparison of 2–5 companies or drugs in ONE parallel call. ALWAYS PREFER over sequential single-pack lookups when comparing entities. type="company" pulls LATEST 10-K revenue + net income + cash + long-term debt from SEC EDGAR/XBRL (off-calendar fiscal years handled correctly — AAPL Sep, NVDA Jan, etc.). type="drug" pulls FAERS adverse-event counts, FDA approval counts, active trial counts. Results sorted by primary metric so "largest" / "most" / "biggest" reads off the top of the response. Returns paired data + pipeworx:// citation URIs per entity. Replaces 8–15 sequential lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valuesYesFor company: 2–5 tickers/CIKs (e.g., ["AAPL","MSFT"]). For drug: 2–5 names (e.g., ["ozempic","mounjaro"]).

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. First observed

TDQS

A4.5/5.0
Behavior4/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Annotations already declare readOnlyHint, openWorldHint, idempotentHint, and destructiveHint. The description adds behavioral specifics: it pulls SEC EDGAR/XBRL data for companies, handles off-calendar fiscal years, and sorts results by primary metric. No contradictions with annotations.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is front-loaded with the core purpose and usage cues. Each sentence adds value, though it is slightly verbose with multiple examples. It efficiently conveys all necessary information without extraneous text.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness4/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

Given the simplicity of the tool (2 parameters, no output schema), the description covers the purpose, parameter usage, return format (paired data + citation URIs), and behavioral notes. It is complete enough for an agent to select and invoke correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters4/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Schema coverage is 100%, so baseline is 3. The description adds meaning beyond the schema by explaining how 'values' should be formatted per entity type (tickers/CIKs vs drug names) and that results are sorted by primary metric, which helps the agent understand parameter usage and output behavior.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description uses specific verbs ('compare', 'side-by-side comparison'), identifies the resources ('companies or drugs'), and provides natural language triggers ('X vs Y'). It clearly distinguishes from sequential lookups by stating it replaces 8–15 sequential calls.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines5/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

The description explicitly states 'ALWAYS PREFER over sequential single-pack lookups when comparing entities,' providing a clear directive on when to use. It also gives example queries and specifies the tool handles 2–5 entities, effectively guiding the agent.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Acled toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.7/5.0
Disambiguation3/5

Many tools have overlapping purposes, especially the Pipeworx query tools (ask_pipeworx, ask_pipeworx_grounded, deep_research) which all serve similar data retrieval needs. Additionally, entity_profile, compare_entities, and recent_changes overlap in providing company information. Polymarket tools also have overlapping analysis functions. This can cause confusion for agents.

Naming Consistency2/5

Tool names are inconsistent in style and convention. Some use underscores (ai_visibility_check, ask_pipeworx), others are single words (forget, recall), and many lack a clear verb_noun pattern (pipeworx_feedback, polymarket_edges). This mixture of naming conventions reduces predictability.

Tool Count3/5

With 32 tools, the count is on the higher side but appropriate given the broad scope covering multiple domains (Pipeworx data, Polymarket betting, ACLED events, npm scanning, memory, etc.). However, some areas have only one or two tools, which feels sparse, and the overall set could be trimmed or better organized.

Completeness3/5

The tool set covers many domains but has notable gaps. For ACLED, only search and count tools exist without any update/delete capabilities. For Pipeworx, the tools are heavily read-focused with no apparent write operations. The broad scope makes completeness hard to assess, but some obvious lifecycle operations are missing.

Resources